Overview

Cabozantinib in Advanced Salivary Gland Cancer Patients

Status:
Terminated
Trial end date:
2019-11-06
Target enrollment:
Participant gender:
Summary
Phase 2 clinical trial on the efficacy of cabozantinib in locally advanced, recurrent and/or metastatic salivary gland cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Radboud University
Collaborator:
Ipsen